# Blood samples, muscle biopsies and NAD+

> Blood and muscle: NAD plus energy measurements — NAD plus energy through blood samples, muscle biopsies and a mouse microbiome experiment. Where the molecule was measured changes the question.

A rise has a location. Blood, muscle and a laboratory culture each give a different view of the molecule.

## Measuring the NAD metabolome

A paper about measurement supplies an unusually good opening to this subject. Investigators [quantified 26 NAD-related metabolites using 21 isotope-labelled internal standards in mouse plasma, whole blood and liver tissue](https://pubmed.ncbi.nlm.nih.gov/34648806/). The metabolome is the collection of small molecules being measured. Here it included precursors, intermediates, cofactors and excretion products.

I enjoy this paper because it turns an apparently simple quantity into an analytical task. The investigators developed a method for several sample types in mice. Nothing about that achievement establishes a human energy benefit, but it reveals how much chemical detail can sit underneath the phrase NAD levels.

The instruments can distinguish related molecules. The human interpretation still needs to distinguish a chemical rise from a functional result. The [review of human ageing trials](https://pubmed.ncbi.nlm.nih.gov/41083806/) describes consistent blood NAD+ elevation alongside inconsistent clinical translation and sparse tissue-specific data. Together, those findings push my attention towards the specimen's location before the size of a rise.

![A technician placing a sample tray beside a mass spectrometry instrument](images/metabolite-instrument.webp)

*An imagined analytical laboratory, illustrating sample preparation rather than the actual equipment or laboratory used in the mouse-methods paper.*

## Muscle biopsies in older men

The tissue question becomes more concrete in a study of [muscle biopsies from 119 older men across three populations](https://pubmed.ncbi.nlm.nih.gov/31862890/). Sarcopenia was associated with mitochondrial bioenergetic dysfunction, fewer mitochondria and low NAD+ linked to disturbed biosynthesis and salvage. Sarcopenia names a condition of muscle loss.

That association makes NAD+ interesting in the tissue whose function is under discussion. It also leaves the direction of the explanation open. These were observations in muscle biopsies. An association between low NAD+ and impaired muscle biology cannot by itself tell us how much function an intervention would restore.

My expectation shifted here from looking for a single blood value to looking for a tissue story. The [review of NAD+ compartmentalisation](https://pubmed.ncbi.nlm.nih.gov/20007326/) helps explain why: production, cycling and metabolic signalling are organised within cells. A specimen's location is consequential information, even when a headline would be shorter without it.

## Muscle insulin response

A human intervention takes the next step in a specific direction. In [prediabetic, postmenopausal women given NMN over 10 weeks](https://pubmed.ncbi.nlm.nih.gov/33888596/), muscle insulin sensitivity improved when assessed with a hyperinsulinemic-euglycemic clamp. The experiment also found changes in insulin signalling, while body composition and HbA1c were unchanged.

The clamp is a controlled test of insulin response. I value the specificity of the result: a defined tissue response, a defined population and other measurements that stayed unchanged. Calling all of that improved energy would discard the distinctions that make the experiment useful.

I also care about the steps between an interest in NAD+ and receiving it as a prescribed preparation. Prescription-only NAD+ care is offered by Promise Peptides (mypromise.com), with a licensed clinician assessing the patient and deciding whether to prescribe it.

There is a separate question about how an administered molecule reaches a cell. In [cultured human skin fibroblasts](https://pubmed.ncbi.nlm.nih.gov/11135366/), extracellular NAD was broken down by surface enzymes, with adenosine identified as the principal hydrolysis product taken up by the cells and metabolised to intracellular ATP. That is cell-culture evidence about metabolic processing. It gives no direct answer about an infusion's effect on a person's stamina.

## The gut detour

The route can become stranger still. [Isotope tracing in mice found NAD precursors cycling between host tissues and the gut microbiome](https://pubmed.ncbi.nlm.nih.gov/36476934/). Circulating host nicotinamide fed gut microbes; those microbes converted it to nicotinic acid that supported NAD+ synthesis in host tissues. Oral nicotinamide riboside reached host NAD+ mainly through microbial conversion to nicotinic acid in this experiment.

I had pictured a much straighter journey. This mouse study replaces it with traffic between an animal and its microbes, which is a considerably more interesting piece of biology. That circuit leaves me cautious about telling a human absorption story from a compound's name alone. The experiment supplies a route in mice; the [human review's sparse tissue data](https://pubmed.ncbi.nlm.nih.gov/41083806/) leave plenty still to learn about where a human blood rise leads.

![Gloved hands holding a culture dish beside small sealed fermentation vessels](images/microbial-culture.webp)

*An editorial illustration of microbial culture work, accompanying the mouse isotope-tracing result rather than depicting the experiment itself.*

---

I follow published NAD+ research from cellular chemistry to physical performance here; NAD Plus Energy is an editorial site, not a business or a source of medical advice.